Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
gc diagnostics is an active healthcare diagnostics business operating as a business unit/brand of goodscare in Germany. The company focuses on commercial point-of-care in vitro diagnostic solutions built around the Igloo Reader Pro and Igloo Pro, portable digital analyzers that interpret lateral flow tests for blood markers, drug tests, and infectious disease assays. Its offering is aimed at pharmacies, clinics, medical practices, elderly care, veterinary settings, laboratories, and research users. Public materials indicate the platform is IVDR-certified and positioned as a bridge between rapid tests and more standardized, digitally documented lab-quality readouts. gc diagnostics appears to be commercially focused rather than a therapeutic drug developer, with revenue generated from device sales, starter kits, and compatible test portfolio expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on gc diagnostics.